Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent international provider of consumer cannabis products, has opened its latest dispensary in Findlay, Ohio, at 2205 Tiffin Avenue, Findlay, OH 45840. This new location enhances Curaleaf's presence in the Buckeye State, now totaling five stores, and increases the company's national retail footprint to 162 locations.
Situated in a vibrant retail and dining hub, Curaleaf Findlay aims to provide both medical patients and adult-use customers with a diverse selection of premium cannabis products. Customers can explore trusted brands and high-quality offerings, including the Select BRIQ all-in-one vape and top-notch flower from Find and Grassroots.
Commitment to Quality and Community
“Expanding into Findlay marks another important step in strengthening our footprint across Ohio and deepening our commitment to the state’s evolving cannabis landscape,” stated Boris Jordan, Curaleaf Chairman and CEO. “This new dispensary reflects our focus on delivering a welcoming, education-driven experience rooted in quality, accessibility, and community engagement. We're proud to serve the people of Findlay and the surrounding Northwest Ohio region, and we look forward to providing both new and returning customers with best-in-class products, expert guidance, and a customer-first mindset.”
Curaleaf Findlay operates from 9:00 AM to 8:00 PM ET, Monday through Saturday, and 9:00 AM to 7:00 PM ET on Sundays. In Ohio, Curaleaf also has retail locations in Cuyahoga Falls, Girard, Lima, and Newark.
For more details on Curaleaf's dispensaries and products across Ohio and beyond, please visit: Curaleaf Dispensaries.
As a leading international cannabis company, Curaleaf is committed to enhancing lives by cultivating and sharing the benefits of cannabis. The company and its brands like Curaleaf, Select, Grassroots, Find, and Anthem are recognized for their quality and reliability across both medical and adult-use markets.
Curaleaf operates a robust distribution network in Europe, Canada, and Australasia, integrating innovative science and research with advanced cultivation and production techniques. For more information about Curaleaf, visit Curaleaf Investor Relations.
This media advisory may contain forward-looking statements. Such statements involve risks and uncertainties that could cause actual results to differ materially from those anticipated. For further information about these risks, please refer to the Company's filings with applicable securities authorities.